Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

95% upper bound limit as per FDA for fully replicate crossover BE study [RSABE / ABEL]

posted by dshah – India, 2021-01-05 09:06 (1625 d 10:33 ago) – Posting: # 22174
Views: 3,643

Hi Yogeshla!

❝ Suppose 95% UB result is 0.001, is it acceptable to FDA?

The 95% UB would not be acceptable for 0.001.

Regards,
dshah

Complete thread:

95% upper bound limit as per FDA for fully replicate crossover BE study yogeshla 2021-01-05 07:01 [RSABE / ABEL]
- 95% upper bound limit as per FDA for fully replicate crossover BE studydshah 2021-01-05 08:06
  - 0.001 > 0 Helmut 2021-01-05 11:01
    - 0.001 > 0 yogeshla 2021-01-05 12:33

Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
42 visitors (0 registered, 42 guests [including 24 identified bots]).
Forum time: 20:39 CEST (Europe/Vienna)

Truth and clarity are complementary. Niels Bohr

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz